Complete Filing Data
CARLSMED, INC. reported Stockholders Equity of $98.87 million for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean CARLSMED, INC. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 |
|---|---|---|
| Net Income Loss | -$29.6M | -$24.3M |
| Selling And Marketing Expense | $35.0M | $21.5M |
| Revenue From Contract With Customer Including Assessed Tax | $50.5M | $27.2M |
| Research And Development Expense | $17.0M | $14.3M |
| Other Nonoperating Income Expense | $940.0K | -$135.0K |
| Operating Income Loss | -$30.6M | -$24.1M |
| Operating Expenses | $68.6M | $44.2M |
| Net Income Loss Available To Common Stockholders Basic | -$30.2M | -$24.8M |
| Interest Expense | $1.4M | $1.3M |
| Gross Profit | $38.0M | $20.0M |
| General And Administrative Expense | $16.6M | $8.4M |
| Cost Of Revenue | $12.5M | $7.1M |
| Comprehensive Income Net Of Tax | -$29.6M | -$24.3M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|---|---|
| Net Income Loss | -$8.5M | -$6.8M | -$5.7M | -$7.8M | -$6.3M | -$5.4M |
| Selling And Marketing Expense | $9.6M | $7.9M | $6.6M | $4.9M | ||
| Revenue From Contract With Customer Including Assessed Tax | $13.1M | $12.1M | $6.6M | $6.1M | ||
| Research And Development Expense | $4.4M | $4.2M | $4.0M | $4.0M | ||
| Other Nonoperating Income Expense | $509.0K | -$264.0K | -$36.0K | $42.0K | ||
| Operating Income Loss | -$9.0M | -$6.5M | -$7.8M | -$6.3M | ||
| Operating Expenses | $19.0M | $15.4M | $12.6M | $10.9M | ||
| Net Income Loss Available To Common Stockholders Basic | -$8.5M | -$6.8M | -$8.4M | -$6.3M | ||
| Interest Expense | $380.0K | $363.0K | $402.0K | $325.0K | ||
| Gross Profit | $9.9M | $8.9M | $4.8M | $4.6M | ||
| General And Administrative Expense | $4.9M | $3.3M | $1.9M | $2.0M | ||
| Cost Of Revenue | $3.1M | $3.2M | $1.8M | $1.5M | ||
| Comprehensive Income Net Of Tax | -$8.5M | -$6.8M | -$7.8M | -$6.3M |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Stockholders Equity | $98.9M | -$70.6M | -$46.1M |
| Restricted Cash | $100.0K | $100.0K | $150.0K |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | $85.9M | $40.2M | $7.4M |
| Cash And Cash Equivalents At Carrying Value | $85.8M | $40.1M | $7.2M |
| Preferred Stock Dividends Income Statement Impact | $584.0K | $592.0K | |
| Allowance For Doubtful Accounts Receivable Write Offs | $414.0K | $368.0K | |
| Retained Earnings Accumulated Deficit | -$100.8M | -$71.2M | |
| Restricted Cash Current | $100.0K | $100.0K | |
| Property Plant And Equipment Net | $1.5M | $260.0K | |
| Prepaid Expense And Other Assets Current | $3.6M | $1.4M | |
| Other Liabilities Noncurrent | $309.0K | $222.0K | |
| Other Assets Noncurrent | $134.0K | $569.0K | |
| Operating Lease Right Of Use Asset | $1.8M | $1.6M | |
| Operating Lease Liability Noncurrent | $1.3M | $1.3M | |
| Operating Lease Liability Current | $752.0K | $449.0K | |
| Noncash Lease Expense | $536.0K | $375.0K | |
| Long Term Debt | $15.3M | $15.4M | |
| Liabilities Current | $14.3M | $8.8M | |
| Liabilities And Stockholders Equity | $130.1M | $51.8M | |
| Liabilities | $31.3M | $26.2M | |
| Inventory Write Down | $1.8M | $1.4M | |
| Inventory Net | $1.8M | $995.0K | |
| Common Stock Value | $0.00 | $0.00 | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | $45.7M | $32.9M | |
| Assets Current | $126.7M | $49.4M | |
| Assets | $130.1M | $51.8M | |
| Allowance For Doubtful Accounts Receivable Current | $1.7M | $1.2M | |
| Accrued Liabilities Current | $3.3M | $2.7M | |
| Accrued Employee Benefits Current | $5.8M | $3.3M | |
| Accounts Receivable Net Current | $11.4M | $6.8M | |
| Accounts Payable Current | $4.5M | $2.4M | |
| Warrant Liabilities | $457.0K | ||
| Vesting Of Early Exercised Common Stock Options | $42.0K | $56.0K | |
| Adjustments To Additional Paid In Capital Dividends In Excess Of Retained Earnings | $584.0K | $592.0K | |
| Right Of Use Asset Obtained In Exchange For Operating Lease Liability | $593.0K | $0.00 | |
| Preferred Stock Warrants Issued In Connection With Term Loan Modifications | $0.00 | $313.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|---|---|
| Stockholders Equity | $106.7M | -$83.1M | -$76.6M | -$66.0M | -$57.7M | -$51.5M |
| Restricted Cash | $100.0K | $100.0K | $100.0K | $100.0K | ||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | $115.5M | $33.6M | $44.5M | $38.2M | ||
| Cash And Cash Equivalents At Carrying Value | $115.4M | $33.5M | $44.4M | $38.1M | ||
| Preferred Stock Dividends Income Statement Impact | $0.00 | $0.00 | $592.0K | $0.00 | ||
| Allowance For Doubtful Accounts Receivable Write Offs | $100.0K | $300.0K | $100.0K | $100.0K | ||
| Retained Earnings Accumulated Deficit | -$92.2M | -$83.7M | ||||
| Restricted Cash Current | $100.0K | $100.0K | ||||
| Property Plant And Equipment Net | $1.2M | $972.0K | ||||
| Prepaid Expense And Other Assets Current | $3.4M | $1.8M | ||||
| Other Liabilities Noncurrent | $290.0K | $267.0K | ||||
| Other Assets Noncurrent | $225.0K | $4.0M | ||||
| Operating Lease Right Of Use Asset | $2.0M | $2.1M | ||||
| Operating Lease Liability Noncurrent | $1.5M | $1.7M | ||||
| Operating Lease Liability Current | $661.0K | $571.0K | ||||
| Noncash Lease Expense | ||||||
| Long Term Debt | $15.4M | $15.4M | ||||
| Liabilities Current | $10.9M | $9.5M | ||||
| Liabilities And Stockholders Equity | $134.9M | $53.3M | ||||
| Liabilities | $28.2M | $27.6M | ||||
| Inventory Write Down | ||||||
| Inventory Net | $1.3M | $1.1M | ||||
| Common Stock Value | $0.00 | $0.00 | ||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | ||||||
| Assets Current | $131.5M | $46.2M | ||||
| Assets | $134.9M | $53.3M | ||||
| Allowance For Doubtful Accounts Receivable Current | $1.6M | $1.6M | ||||
| Accrued Liabilities Current | $3.2M | $3.2M | ||||
| Accrued Employee Benefits Current | $4.4M | $3.1M | ||||
| Accounts Receivable Net Current | $11.3M | $9.7M | ||||
| Accounts Payable Current | $2.7M | $2.6M | ||||
| Warrant Liabilities | $32.0K | $727.0K | ||||
| Vesting Of Early Exercised Common Stock Options | ||||||
| Adjustments To Additional Paid In Capital Dividends In Excess Of Retained Earnings | $584.0K | $592.0K | ||||
| Right Of Use Asset Obtained In Exchange For Operating Lease Liability | ||||||
| Preferred Stock Warrants Issued In Connection With Term Loan Modifications |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 |
|---|---|---|
| Share Based Compensation | $1.9M | $253.0K |
| Proceeds From Stock Options Exercised | $205.0K | $34.0K |
| Proceeds From Issuance Of Convertible Preferred Stock | $11.9M | $52.3M |
| Payments To Acquire Property Plant And Equipment | $642.0K | $180.0K |
| Net Cash Provided By Used In Operating Activities | -$29.0M | -$25.5M |
| Net Cash Provided By Used In Investing Activities | -$25.5M | -$180.0K |
| Net Cash Provided By Used In Financing Activities | $100.1M | $58.5M |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | $2.3M | $720.0K |
| Increase Decrease In Operating Lease Liability | -$290.0K | -$310.0K |
| Increase Decrease In Inventories | $2.7M | $1.8M |
| Increase Decrease In Deferred Compensation | $2.5M | $1.2M |
| Increase Decrease In Accrued Liabilities | $627.0K | $1.2M |
| Increase Decrease In Accounts Receivable | $5.0M | $4.0M |
| Increase Decrease In Accounts Payable | $2.3M | $297.0K |
| Depreciation Depletion And Amortization | $281.0K | $145.0K |
| Proceeds From Debt Net Of Issuance Costs | $0.00 | $6.2M |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 |
|---|---|---|
| Weighted Average Number Of Shares Outstanding Basic | 14.2M | 4.1M |
| Weighted Average Number Of Diluted Shares Outstanding | 14.2M | 4.1M |
| Earnings Per Share Diluted | $-2.12 | $-6.11 |
| Earnings Per Share Basic | $-2.12 | $-6.11 |
| Common Stock Shares Outstanding | 26.6M | 4.1M |
| Common Stock Shares Issued | 26.7M | 4.2M |
| Common Stock Shares Authorized | 600.0M | 21.8M |
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Weighted Average Number Of Shares Outstanding Basic | 21.1M | 4.6M | 4.1M | 4.1M |
| Weighted Average Number Of Diluted Shares Outstanding | 21.1M | 4.6M | 4.1M | 4.1M |
| Earnings Per Share Diluted | $-0.40 | $-1.47 | $-2.06 | $-1.55 |
| Earnings Per Share Basic | $-0.40 | $-1.47 | $-2.06 | $-1.55 |
| Common Stock Shares Outstanding | 26.6M | 4.6M | ||
| Common Stock Shares Issued | 26.7M | 4.7M | ||
| Common Stock Shares Authorized | 600.0M | 23.7M | ||
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 |
|---|---|---|
| Stock Issued During Period Value Stock Options Exercised | $205.0K | $34.0K |
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $1.9M | $253.0K |
| Investment Income Interest | $2.7M | $1.3M |
| Fair Value Adjustment Of Warrants | $328.0K | $144.0K |
| Adjustments To Additional Paid In Capital Sharebased Compensation And Exercise Of Stock Options | $42.0K | $56.0K |
| Noncash Interest | $206.0K | $206.0K |
| Additional Paid In Capital | $199.7M | $541.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|---|---|
| Stock Issued During Period Value Stock Options Exercised | $1.0K | $34.0K | $149.0K | $4.0K | $11.0K | $12.0K |
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $704.0K | $258.0K | $175.0K | $66.0K | $52.0K | $35.0K |
| Investment Income Interest | $954.0K | $336.0K | $394.0K | $428.0K | ||
| Fair Value Adjustment Of Warrants | $65.0K | $237.0K | $28.0K | $61.0K | ||
| Adjustments To Additional Paid In Capital Sharebased Compensation And Exercise Of Stock Options | $11.0K | $10.0K | $10.0K | $45.0K | ||
| Noncash Interest | ||||||
| Additional Paid In Capital | $198.9M | $593.0K |
Most recent annual filing with the SEC: February 25, 2026
Data sourced from SEC EDGAR public filings as of August 8, 2026.